Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2022-03-07 - Introduced in the Senate, Referred to Senate Commerce Committee [S2143 Detail]

Text: Latest bill text (Introduced) [HTML]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey S2143 at this time.